Latest Regulatory Approvals News

Empire Energy has successfully drilled its longest well to date, secured a $65 million financing package, and received environmental approval for its Carpentaria Pilot Project, setting the stage for first gas deliveries later in 2025.

EMVision Medical Devices reports strong progress in clinical trials for its emu™ Bedside Scanner, backed by robust cash reserves and strategic non-dilutive funding. The company is poised to commence pivotal FDA validation trials, marking a key step toward commercialisation.

Terramin's December 2024 quarterly report reveals major progress at its Tala Hamza Zinc Project with land acquisition and a $336 million EPC contract, while the Bird in Hand Gold Project faces a legal hurdle after the Supreme Court dismissed its mining lease application.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.

Westar Resources reports exceptional gold and silver assay results from its Mindoolah Mining Centre, setting the stage for imminent drilling programs in early 2025. The company maintains a strong cash position while strategically focusing on high-potential projects.

Argosy Minerals has reported significant progress on its flagship Rincon Lithium Project, including an upgraded mineral resource estimate and advancing engineering and feasibility studies toward a 12,000tpa lithium carbonate operation.

Auswide Bank has secured Treasurer approval for MyState Bank’s acquisition via a scheme of arrangement, setting the stage for a pivotal shareholder vote in early February.

MyState Limited has secured Federal Treasurer approval for its merger with Auswide Bank, advancing plans to create a larger regional banking group pending shareholder and court consent.

360 Capital Group has announced a fully franked dividend of AUD 0.02 per security for the six months ending December 31, 2024, payable on January 24, 2025. This update confirms the payment details and clarifies the distribution source.

Altamin Limited has completed the acquisition of Appian Italy’s 29.85% stake in Vedra Metals, gaining 100% ownership of the Gorno Project and positioning itself for streamlined development or sale.

Delta Lithium reports promising drilling outcomes at its fully permitted Mt Ida Gold Project, confirming resource growth potential and endorsing a standalone development strategy.

Clarity Pharmaceuticals has secured a second FDA Fast Track Designation for its 64Cu-SAR-bisPSMA diagnostic agent, aiming to revolutionize prostate cancer imaging and speed regulatory approval.